Special correspondent for Vanity Fair Gabriel Sherman joins The Hive to discuss the rise and fall of Steve Bannon. Sherman reports on his story regarding the rift between Bannon and President Trump.
Sherman talks about Bannon's flat-footed response to Trump's anger and whether he may have misjudged his own actions. Kelly, Scholer, and Sherman debate whether a return to Trump's White House is possible for Bannon.
They also discuss the possibility of Bannon starting another nationalist media organization and whether Bannon's fall from grace signals that he is not the political kingmaker some made him out to be.
The Congressional Budget Office expects the U.S. economy will grow at a 4.6% annual rate this year, but with employment not returning to pre-pandemic levels until 2024.
President Joe Biden is warning of a growing “cost of inaction” on his $1.9 trillion COVID relief plan.
From Wall Street to Silicon Valley, these are the top stories that moved markets and had investors, business leaders, and entrepreneurs talking this week on Cheddar.
Event organizers and other unconventional logistics experts are using their skills to help the nation vaccinate as many people against COVID-19 as possible.
The wave of small investors who have ballooned the price of GameStop stock in an unprecedented short squeeze are calling on each other to hold their positions even as trading platforms freeze additional sales.
Variants and Vaccines, Robinhood Under Fire & World's Biggest Rollercoaster
Consumers slowed their spending for a second straight month in a worrisome sign for an economy struggling under the weight of a still out-of-control pandemic.
The independent senator says multiple groups will benefit from the proceeds, including Meals on Wheels and Vermont community action agencies. He also says Getty Images will donate proceeds as part of a licensing agreement.
New York may have undercounted COVID-19 deaths among nursing home residents by thousands.
Employers weigh the pros and cons of potentially mandating workers get the COVID vaccine or incentivizing them to get the shots, a conundrum complicated by legal considerations.
